1099.HK - Sinopharm Group Co. Ltd.

HKSE - HKSE Preço Adiado. Moeda em HKD.

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn

Setor(es)Healthcare
IndústriaMedical Distribution
Funcionários Integrais114.766

Principais Executivos

NomeTítuloPagarExercidoNascido em
Mr. Qingming YuExec. Chairman912,44kN/A1964
Mr. Yong LiuPres & Exec. Director882,36kN/A1969
Ms. Xiaojuan LiChief Financial OfficerN/AN/A1976
Mr. Yijian WuSec. to the Board, Company Sec. & Authorised RepresentativeN/AN/A1970
Os valores são a partir de 31 de dezembro de 2022, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em HKD.

Descrição

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Governança Corporativa

O QualityScore de governança da ISS da Sinopharm Group Co. Ltd. a partir de 1 de junho de 2023 é 5. As principais pontuações para Auditoria são: 6; Conselho: 7; Direitos de Acionistas: 9; Compensação: 2.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.